Breast cancer--loss of PTEN predicts resistance to treatment.
关键词:
摘要: A new study uncovers a mechanism by which trastuzumab (Herceptin) counters the progression of cancer. The findings point to subgroup patients who are likely have response treatment.
sci-hub.se 参考文章(5)
Antonio Di Cristofano, Pier Paolo Pandolfi, The Multiple Roles of PTEN in Tumor Suppression Cell. ,vol. 100, pp. 387- 390 ,(2000) , 10.1016/S0092-8674(00)80674-1
Lloyd C Trotman, Masaru Niki, Zohar A Dotan, Jason A Koutcher, Antonio Di Cristofano, Andrew Xiao, Alan S Khoo, Pradip Roy-Burman, Norman M Greenberg, Terry Van Dyke, Carlos Cordon-Cardo, Pier Paolo Pandolfi, Pten dose dictates cancer progression in the prostate. PLOS Biology. ,vol. 1, ,(2003) , 10.1371/JOURNAL.PBIO.0000059
Philip Stephens, Chris Hunter, Graham Bignell, Sarah Edkins, Helen Davies, Jon Teague, Claire Stevens, Sarah O'meara, Raffaella Smith, Adrian Parker, Andy Barthorpe, Matthew Blow, Lisa Brackenbury, Adam Butler, Oliver Clarke, Jennifer Cole, Ed Dicks, Angus Dike, Anja Drozd, Ken Edwards, Simon Forbes, Rebecca Foster, Kristian Gray, Chris Greenman, Kelly Halliday, Katy Hills, Vivienne Kosmidou, Richard Lugg, Andy Menzies, Janet Perry, Robert Petty, Keiran Raine, Lewis Ratford, Rebecca Shepherd, Alexandra Small, Yvonne Stephens, Calli Tofts, Jennifer Varian, Sofie West, Sara Widaa, Andrew Yates, Francis Brasseur, Colin S Cooper, Adrienne M Flanagan, Margaret Knowles, Suet Y Leung, David N Louis, Leendert HJ Looijenga, Bruce Malkowicz, Marco A Pierotti, Bin Teh, Georgia Chenevix-Trench, Barbara L Weber, Siu T Yuen, Grace Harris, Peter Goldstraw, Andrew G Nicholson, P Andrew Futreal, Richard Wooster, Michael R Stratton, None, Intragenic ERBB2 kinase mutations in tumours Nature. ,vol. 431, pp. 525- 526 ,(2004) , 10.1038/431525B
Yoichi Nagata, Keng-Hsueh Lan, Xiaoyan Zhou, Ming Tan, Francisco J. Esteva, Aysegul A. Sahin, Kristine S. Klos, Ping Li, Brett P. Monia, Nina T. Nguyen, Gabriel N. Hortobagyi, Mien-Chie Hung, Dihua Yu, PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients Cancer Cell. ,vol. 6, pp. 117- 127 ,(2004) , 10.1016/J.CCR.2004.06.022
Dihua Yu, Mien-Chie Hung, Overexpression of ErbB2 in cancer and ErbB2-targeting strategies. Oncogene. ,vol. 19, pp. 6115- 6121 ,(2000) , 10.1038/SJ.ONC.1203972